Among patients whose pT stage, pN stage, tumor stage, ER status, PR status, and HER2 status were known, 75.8% (294/388) had stage T2-T4 SCCB, and 73.6% (293/398) had negative lymph nodes. This evidence concerns the gene ESR1 and urinary bladder small cell neuroendocrine carcinoma.